{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:01:28Z","timestamp":1773496888455,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008303","name":"Department for Employment and Learning, Northern Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008303","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bbrc.2019.09.059","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T16:25:02Z","timestamp":1568651102000},"page":"579-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of vitamin D as a regulator of androgen intracrinology in LNCAP prostate cancer cells"],"prefix":"10.1016","volume":"519","author":[{"given":"Karl W.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna Patricia","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego F.","family":"Cobice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.09.059_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","article-title":"Studies on prostatic cancer: II. The effects of castration on advanced carcinoma of the prostate gland","volume":"43","author":"Huggins","year":"1941","journal-title":"Arch. Surg."},{"key":"10.1016\/j.bbrc.2019.09.059_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/pros.21297","article-title":"Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in\u00a0vivo","volume":"71","author":"Abedinpour","year":"2011","journal-title":"The Prostate"},{"key":"10.1016\/j.bbrc.2019.09.059_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/1078-0432.CCR-1146-03","article-title":"The androgen axis in recurrent prostate cancer","volume":"10","author":"Mohler","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2019.09.059_bib4","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1158\/0008-5472.CAN-07-5997","article-title":"Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer","volume":"68","author":"Locke","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2019.09.059_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In\u00a0vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"Visakorpi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2019.09.059_bib6","first-page":"2892","article-title":"Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen","volume":"61","author":"Gregory","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2019.09.059_bib7","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1530\/EC-17-0118","article-title":"Clinical relevance of androgen receptor alterations in prostate cancer","volume":"6","author":"Jernberg","year":"2017","journal-title":"Endocrine Connect."},{"key":"10.1016\/j.bbrc.2019.09.059_bib8","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/pros.22655","article-title":"Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis","volume":"73","author":"Kumagai","year":"2013","journal-title":"The Prostate"},{"key":"10.1016\/j.bbrc.2019.09.059_bib9","first-page":"365","article-title":"Mechanisms of resistance in castration-resistant prostate cancer (CRPC)","volume":"4","author":"Chandrasekar","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.bbrc.2019.09.059_bib10","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1073\/pnas.1107898108","article-title":"Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer","volume":"108","author":"Chang","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2019.09.059_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsbmb.2005.11.011","article-title":"Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity","volume":"99","author":"Mo","year":"2006","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbrc.2019.09.059_bib12","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/1078-0432.CCR-08-1171","article-title":"Castration-resistant prostate cancer: locking up the molecular escape routes","volume":"15","author":"Attar","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2019.09.059_bib13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/cncr.31161","article-title":"Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC)","volume":"124","author":"Pal","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2019.09.059_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.rdc.2012.03.014","article-title":"The role of vitamin D in cancer prevention and treatment","volume":"38","author":"Krishnan","year":"2012","journal-title":"Rheum. Dis. Clin."},{"key":"10.1016\/j.bbrc.2019.09.059_bib15","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/endo.132.5.7682937","article-title":"Vitamin D and prostate cancer: 1, 25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines","volume":"132","author":"Skowronski","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2019.09.059_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1359\/jbmr.1998.13.3.325","article-title":"The nuclear vitamin D receptor: biological and molecular regulatory properties revealed","volume":"13","author":"Haussler","year":"1998","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.bbrc.2019.09.059_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbalip.2011.01.004","article-title":"1\u03b1, 25-Dihydroxyvitamin D 3 exerts tissue-specific effects on estrogen and androgen metabolism","volume":"1811","author":"Lundqvist","year":"2011","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbrc.2019.09.059_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/pros.22748","article-title":"Vitamin D receptor agonist EB1089 is a potent regulator of prostatic \u201cintracrine\u201d metabolism","volume":"74","author":"Doherty","year":"2014","journal-title":"The Prostate"},{"key":"10.1016\/j.bbrc.2019.09.059_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2012.08.007","article-title":"Regulation of CYP3A4 and CYP3A5 expression and modulation of \u201cintracrine\u201d metabolism of androgens in prostate cells by liganded vitamin D receptor","volume":"364","author":"Maguire","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2019.09.059_bib20","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M112.390047","article-title":"Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4","author":"Cheng","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.09.059_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/dmd.32.3.305","article-title":"Stereo-and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450","volume":"32","author":"Miller","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2019.09.059_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0304-4165(97)00156-6","article-title":"Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells","volume":"1380","author":"Ohmori","year":"1998","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bbrc.2019.09.059_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.urology.2009.02.033","article-title":"Expression of cytochrome P450 3A4 and its clinical significance in human prostate cancer","volume":"74","author":"Fujimura","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.bbrc.2019.09.059_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bcp.2017.12.013","article-title":"Quantification of 11\u03b2-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice","volume":"148","author":"Cobice","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2019.09.059_bib25","doi-asserted-by":"crossref","first-page":"11576","DOI":"10.1021\/ac402777k","article-title":"Mass spectrometry imaging for dissecting steroid intracrinology within target tissues","volume":"85","author":"Cobice","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbrc.2019.09.059_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jsbmb.2007.02.009","article-title":"Regulation of 17\u03b2-hydroxysteroid dehydrogenase type 2, type 4 and type 5 by calcitriol, LXR agonist and 5\u03b1-dihydrotestosterone in human prostate cancer cells","volume":"107","author":"Wang","year":"2007","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbrc.2019.09.059_bib27","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/j.1464-410X.2012.11445.x","article-title":"Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)","volume":"110","author":"Tsao","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.bbrc.2019.09.059_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0006-291X(05)80067-1","article-title":"A\u00a0mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens","volume":"173","author":"Veldscholte","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2019.09.059_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajur.2016.08.001","article-title":"Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer","volume":"3","author":"Armstrong","year":"2016","journal-title":"Asian J. Urol."},{"key":"10.1016\/j.bbrc.2019.09.059_bib30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","article-title":"The backdoor pathway to dihydrotestosterone","volume":"15","author":"Auchus","year":"2004","journal-title":"Trends Endocrinol. Metab."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19317802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19317802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:41:45Z","timestamp":1757763705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19317802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0006291X19317802"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.059","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of vitamin D as a regulator of androgen intracrinology in LNCAP prostate cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}